Please wait a minute...
浙江大学学报（医学版）
浙江大学学报（医学版）  2020, Vol. 49 Issue (5): 637-643    DOI: 10.3785/j.issn.1008-9292.2020.08.13
综述     
正五聚蛋白3在多囊卵巢综合征中的作用研究进展
吴唯1(),徐键1,2,*()
1. 浙江大学医学院附属妇产科医院生殖内分泌科, 浙江 杭州 310006
2. 浙江大学医学院附属第四医院妇产科, 浙江 义乌 322000
Research progress on the role of pentraxin 3 in polycystic ovary syndrome
WU Wei1(),XU Jian1,2,*()
1. Department of Reproductive Endocrinology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou 310006, China
2. Department of Gynecology and Obstetrics, the Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu 322000, Zhejiang Province, China
 全文: PDF(1070 KB)   HTML( 6 )
摘要：

多囊卵巢综合征（PCOS）是育龄妇女常见的内分泌疾病，是女性不孕的主要原因之一。正五聚蛋白3（PTX3）是一类多功能蛋白质，具有一系列生物活性作用。PTX3参与调节胰岛素分泌及葡萄糖代谢、卵巢卵丘细胞功能、炎症因子活动、雄激素代谢、脂质吸收转运、内皮细胞功能，进而发挥改善胰岛素抵抗、促进卵泡发育与排卵、减弱慢性炎症反应、抑制雄激素水平、改善脂代谢异常和预防动脉粥样硬化及心血管疾病等作用，参与PCOS及其并发症的发生。本文就PTX3在PCOS及其并发症中的作用机制进行综述，以期为PCOS发病机制的深入研究及临床诊疗提供新的思路与方向。
关键词： 正五聚蛋白3;  多囊卵巢综合征;  胰岛素抵抗;  卵泡发育;  炎症反应;  脂代谢;  雄激素;  综述    
Abstract:

Polycystic ovary syndrome (PCOS) is a common endocrine disease of child-bearing period women and one of the main causes of infertility in women. Pentraxin 3 (PTX3) is a multifunctional protein with a series of biological activities. PTX3 participates in the regulation of insulin secretion and glucose metabolism, ovarian cumulus cell function, inflammatory factor activity, androgen metabolism, lipid absorption and transport, and endothelial cell function, thereby improving insulin resistance, promoting follicular development and ovulation, reducing chronic inflammation, inhibiting androgen levels, improving lipid metabolism abnormalities and preventing atherosclerosis and cardiovascular diseases, thus participating in the occurrence of PCOS and its complications. This article reviews the mechanism of PTX3 in PCOS and its complications, trying to provide new ideas and directions for the study of PCOS pathogenesis and its clinical diagnosis and treatment.
Key words: Pentraxin 3    Polycystic ovary syndrome    Insulin resistance    Follicular development    Inflammatory reaction    Lipid metabolism    Androgen    Review
收稿日期: 2020-02-03 出版日期: 2020-11-19
:  R711.75  
基金资助: 国家重点研发计划(2019YFC0121000)
通讯作者: 徐键     E-mail: 21718414@zju.edu.cn;xuj@zju.edu.cn
作者简介: 吴唯(1993-), 女, 硕士研究生, 主要从事生殖内分泌研究; E-mail:21718414@zju.edu.cn; https://orcid.org/0000-0003-1795-2326
服务　　
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章　　
吴唯
徐键

引用本文:

吴唯,徐键. 正五聚蛋白3在多囊卵巢综合征中的作用研究进展[J]. 浙江大学学报（医学版）, 2020, 49(5): 637-643.

WU Wei,XU Jian. Research progress on the role of pentraxin 3 in polycystic ovary syndrome. J Zhejiang Univ (Med Sci), 2020, 49(5): 637-643.

链接本文:

http://www.zjujournals.com/med/CN/10.3785/j.issn.1008-9292.2020.08.13    或    http://www.zjujournals.com/med/CN/Y2020/V49/I5/637

1 LI R , ZHANG Q , YANG D et al. Prevalence of polycystic ovary syndrome in women in China:a large community-based study[J]. Hum Reprod, 2013, 28 (9): 2562- 2569
doi: 10.1093/humrep/det262
2 NOLAN C J , PRENTKI M . Insulin resistance and insulin hypersecretion in the metabolic syndrome and type 2 diabetes:Time for a conceptual framework shift[J]. Diab Vasc Dis Res, 2019, 16 (2): 118- 127
doi: 10.1177/1479164119827611
3 DIAMANTI-KANDARAKIS E , PAPAVASSILIOU A G , KANDARAKIS S A et al. Pathophysiology and types of dyslipidemia in PCOS[J]. Trends Endocrinol Metab, 2007, 18 (7): 280- 285
doi: 10.1016/j.tem.2007.07.004
4 SHORAKAE S , TEEDE H , DE COURTEN B et al. The emerging role of chronic low-grade inflammation in the pathophysiology of polycystic ovary syndrome[J]. Semin Reprod Med, 2015, 33 (4): 257- 269
doi: 10.1055/s-0035-1556568
5 COONEY L G , DOKRAS A . Beyond fertility:polycystic ovary syndrome and long-term health[J]. Fertil Steril, 2018, 110 (5): 794- 809
doi: 10.1016/j.fertnstert.2018.08.021
6 BONAVITA E , GENTILE S , RUBINO M et al. PTX3 is an extrinsic oncosuppressor regulating complement-dependent inflammation in cancer[J]. Cell, 2015, 160 (4): 700- 714
doi: 10.1016/j.cell.2015.01.004
7 BOTTAZZI B , INFORZATO A , MESSA M et al. The pentraxins PTX3 and SAP in innate immunity, regulation of inflammation and tissue remodelling[J]. J Hepatol, 2016, 64 (6): 1416- 1427
doi: 10.1016/j.jhep.2016.02.029
8 CAMAIONI A , KLINGER F G , CAMPAGNOLO L et al. The influence of pentraxin 3 on the ovarian function and its impact on fertility[J]. Front Immunol, 2018, 9 2808
doi: 10.3389/fimmu.2018.02808
9 LEALI D , ALESSI P , COLTRINI D et al. Long pentraxin-3 inhibits FGF8b-dependent angiogenesis and growth of steroid hormone-regulated tumors[J]. Mol Cancer Ther, 2011, 10 (9): 1600- 1610
doi: 10.1158/1535-7163.MCT-11-0286
10 WEISS E P , REEDS D N , EZEKIEL U R et al. Circulating cytokines as determinants of weight loss-induced improvements in insulin sensitivity[J]. Endocrine, 2017, 55 (1): 153- 164
doi: 10.1007/s12020-016-1093-4
11 LEE R , AHN H R , SHIN M H et al. Association of plasma pentraxin-3 level with lipid levels and cardiovascular risk factors in people with no history of lipid-lowering medication:the dong-gu study[J]. J Atheroscler Thromb, 2019, 26 (8): 738- 745
doi: 10.5551/jat.47167
12 NORATA G D , MARCHESI P , PULAKAZHI VENU V K et al. Deficiency of the long pentraxin PTX3 promotes vascular inflammation and atherosclerosis[J]. Circulation, 2009, 120 (8): 699- 708
doi: 10.1161/CIRCULATIONAHA.108.806547
13 DIAMANTI-KANDARAKIS E , DUNAIF A . Insulin resistance and the polycystic ovary syndrome revisited:an update on mechanisms and implications[J]. Endocr Rev, 2012, 33 (6): 981- 1030
doi: 10.1210/er.2011-1034
14 JEANES Y M , REEVES S . Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome:diagnostic and methodological challenges[J]. Nutr Res Rev, 2017, 30 (1): 97- 105
doi: 10.1017/S0954422416000287
15 SAHIN F K , SAHIN S B , BALIK G et al. Does low pentraxin-3 levels associate with polycystic ovary syndrome and obesity?[J]. Int J Clin Exp Med, 2014, 7 (10): 3512- 3519
16 OSORIO-CONLES O, GUITART M, CHACÓN M R, et al. Plasma PTX3 protein levels inversely correlate with insulin secretion and obesity, whereas visceral adipose tissue PTX3 gene expression is increased in obesity[J/OL]. Am J Physiol Endocrinol Metab, 2011, 301(6): E1254-E1261. DOI: 10.1152/ajpendo.00163.2011.
17 MIYAKI A , CHOI Y , MAEDA S . Pentraxin 3 production in the adipose tissue and the skeletal muscle in diabetic-obese mice[J]. Am J Med Sci, 2014, 347 (3): 228- 233
doi: 10.1097/MAJ.0b013e31828341af
18 SLUSHER A L , HUANG C J . Association of pentraxin 3 with insulin resistance and glucose response following maximal aerobic exercise in obese and normal-mass individuals[J]. Can J Physiol Pharmacol, 2016, 94 (7): 734- 738
doi: 10.1139/cjpp-2015-0464
19 FRANKS S , STARK J , HARDY K . Follicle dynamics and anovulation in polycystic ovary syndrome[J]. Hum Reprod Update, 2008, 14 (4): 367- 378
doi: 10.1093/humupd/dmn015
20 DUMESIC D A , OBERFIELD S E , STENER-VICTORIN E et al. Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome[J]. Endocr Rev, 2015, 36 (5): 487- 525
doi: 10.1210/er.2015-1018
21 SALUSTRI A , GARLANDA C , HIRSCH E et al. PTX3 plays a key role in the organization of the cumulus oophorus extracellular matrix and in in vivo fertilization[J]. Development, 2004, 131 (7): 1577- 1586
doi: 10.1242/dev.01056
22 BRIGGS D C , BIRCHENOUGH H L , ALI T et al. Metal ion-dependent heavy chain transfer activity of TSG-6 mediates assembly of the cumulus-oocyte matrix[J]. J Biol Chem, 2015, 290 (48): 28708- 28723
doi: 10.1074/jbc.M115.669838
23 TOSI F , DI SARRA D , BONIN C et al. Plasma levels of pentraxin-3, an inflammatory protein involved in fertility, are reduced in women with polycystic ovary syndrome[J]. Eur J Endocrinol, 2014, 170 (3): 401- 409
doi: 10.1530/EJE-13-0761
24 CILLO F , BREVINI T A , ANTONINI S et al. Association between human oocyte developmental competence and expression levels of some cumulus genes[J]. Reproduction, 2007, 134 (5): 645- 650
doi: 10.1530/REP-07-0182
25 LI X , WANG H , SHENG Y et al. MicroRNA-224 delays oocyte maturation through targeting Ptx3 in cumulus cells[J]. Mech Dev, 2017, 143 20- 25
doi: 10.1016/j.mod.2016.12.004
26 ANAGNOSTIS P , TARLATZIS B C , KAUFFMAN R P . Polycystic ovarian syndrome (PCOS):Long-term metabolic consequences[J]. Metabolism, 2018, 86 33- 43
doi: 10.1016/j.metabol.2017.09.016
27 DEBAN L , RUSSO R C , SIRONI M et al. Regulation of leukocyte recruitment by the long pentraxin PTX3[J]. Nat Immunol, 2010, 11 (4): 328- 334
doi: 10.1038/ni.1854
28 PEREA L , COLL M , SANJURJO L et al. Pentraxin-3 modulates lipopolysaccharide-induced inflammatory response and attenuates liver injury[J]. Hepatology, 2017, 66 (3): 953- 968
doi: 10.1002/hep.29215
29 RUBINO M, KUNDERFRANCO P, BASSO G, et al. Epigenetic regulation of the extrinsic oncosuppressor PTX3 gene in inflammation and cancer[J/OL]. Oncoimmunology, 2017, 6(7): e1333215. DOI: 10.1080/2162402X.2017.1333215.
30 PADMANABHAN V , VEIGA-LOPEZ A , HERKIMER C et al. Developmental programming:prenatal and postnatal androgen antagonist and insulin sensitizer interventions prevent advancement of puberty and improve lh surge dynamics in prenatal testosterone-treated sheep[J]. Endocrinology, 2015, 156 (7): 2678- 2692
doi: 10.1210/en.2015-1235
31 RONCA R , ALESSI P , COLTRINI D et al. Long pentraxin-3 as an epithelial-stromal fibroblast growth factor-targeting inhibitor in prostate cancer[J]. J Pathol, 2013, 230 (2): 228- 238
doi: 10.1002/path.4181
32 PILTONEN T , PUURUNEN J , HEDBERG P et al. Oral, transdermal and vaginal combined contraceptives induce an increase in markers of chronic inflammation and impair insulin sensitivity in young healthy normal-weight women:a randomized study[J]. Hum Reprod, 2012, 27 (10): 3046- 3056
doi: 10.1093/humrep/des225
33 GIACOMINI A , MATARAZZO S , PAGANO K et al. A long pentraxin-3-derived pentapeptide for the therapy of FGF8b-driven steroid hormone-regulated cancers[J]. Oncotarget, 2015, 6 (15): 13790- 13802
doi: 10.18632/oncotarget.3831
34 李宣, 丁卫, 刘嘉茵 et al. 血脂异常对多囊卵巢综合征患者IVF/ICSI妊娠结局的影响[J]. 中华妇产科杂志, 2018, 53 (6): 402- 408
LI Xuan , DING Wei , LIU Jiayin et al. Effects of dyslipidemia on IVF/ICSI pregnancy outcome in patients with polycystic ovary syndrome[J]. Chinese Journal of Obstetrics and Gynecology, 2018, 53 (6): 402- 408
doi: 10.3760/cma.j.issn.0529-567x.2018.06.008
35 CASULA M , MONTECUCCO F , BONAVENTURA A et al. Update on the role of Pentraxin 3 in atherosclerosis and cardiovascular diseases[J]. Vascul Pharmacol, 2017, 99 1- 12
doi: 10.1016/j.vph.2017.10.003
36 张雨, 胡红琳, 王岩 et al. 初诊多囊卵巢综合征患者空腹血清Pentraxin3的水平变化及意义[J]. 安徽医科大学学报, 2016, 51 (6): 883- 887
ZHANG Yu , HU Honglin , WANG Yan et al. Changes and significance of fasting serum Pentraxin3 levels in patients with newly-diagnosed polycystic ovarian syndrome[J]. Acta Universitatis Medicinalis Anhui, 2016, 51 (6): 883- 887
37 WITASP A , CARRERO J J , MICHA?LSSON K et al. Inflammatory biomarker pentraxin 3(PTX3) in relation to obesity, body fat depots and weight loss[J]. Obesity (Silver Spring), 2014, 22 (5): 1373- 1379
doi: 10.1002/oby.20695
38 LEKVA T , MICHELSEN A E , BOLLERSLEV J et al. Low circulating pentraxin 3 levels in pregnancy is associated with gestational diabetes and increased apoB/apoA ratio:a 5-year follow-up study[J]. Cardiovasc Diabetol, 2016, 15 23
doi: 10.1186/s12933-016-0345-1
39 TRIPATHY P , SAHU A , SAHU M et al. Ultrasonographic evaluation of intra-abdominal fat distribution and study of its influence on subclinical atherosclerosis in women with polycystic ovarian syndrome[J]. Eur J Obstet Gynecol Reprod Biol, 2017, 217 18- 22
doi: 10.1016/j.ejogrb.2017.08.011
40 HART R , DOHERTY D A . The potential implications of a PCOS diagnosis on a woman's long-term health using data linkage[J]. J Clin Endocrinol Metab, 2015, 100 (3): 911- 919
doi: 10.1210/jc.2014-3886
41 O'NEILL C L , GUDURIC-FUCHS J , CHAMBERS S E et al. Endothelial cell-derived pentraxin 3 limits the vasoreparative therapeutic potential of circulating angiogenic cells[J]. Cardiovasc Res, 2016, 112 (3): 677- 688
doi: 10.1093/cvr/cvw209
42 WYSKIDA K , FRANIK G , POHL N et al. Pentraxin 3 as a marker of endothelial dysfunction in young women with polycystic ovary syndrome (PCOS)[J]. Scand J Clin Lab Invest, 2019, 79 (6): 419- 423
doi: 10.1080/00365513.2019.1637535
43 MORISHITA T , UZUI H , NAKANO A et al. Association of plasma pentraxin-3 levels with coronary risk factors and the lipid profile:a cross-sectional study in Japanese patients with stable angina pectoris[J]. Heart Vessels, 2018, 33 (11): 1301- 1310
doi: 10.1007/s00380-018-1191-8
[1] 李梦瑶, 刘盼, 柯越海, 张雪. 放射性肺损伤中巨噬细胞作用机制的研究进展[J]. 浙江大学学报（医学版）, 2020, 49(5): 623-628.
[2] 韩雪, 蒋国军, 石巧娟. 降血糖药对内皮祖细胞作用的研究进展[J]. 浙江大学学报（医学版）, 2020, 49(5): 629-636.
[3] 段润平, 许叶圣, 郑利斌, 姚玉峰. 病毒感染性眼病病原学诊断的研究进展[J]. 浙江大学学报（医学版）, 2020, 49(5): 644-650.
[4] 徐清霖,楼国东,王甜甜,张力三. 发作性睡病的药物治疗进展[J]. 浙江大学学报（医学版）, 2020, 49(4): 419-424.
[5] 蒋沛然,王志萍. 模式生物神经轴突再生的研究进展[J]. 浙江大学学报（医学版）, 2020, 49(4): 500-507.
[6] 陈峻逸,杨翔,方学贤,王福俤,闵军霞. 铁死亡与重大慢性疾病[J]. 浙江大学学报（医学版）, 2020, 49(1): 44-57.
[7] 俞卿, 熊秀芳, 孙毅. 靶向Cullin-RING E3泛素连接酶的抗肿瘤策略及相关药物研发进展[J]. 浙江大学学报（医学版）, 2020, 49(1): 1-19.
[8] 段玲艳,尹香菊,孟红恩,方学贤,闵军霞,王福俤. 铁稳态代谢表观遗传调控机制的研究进展[J]. 浙江大学学报（医学版）, 2020, 49(1): 58-70.
[9] 李艾,张添源,高建青. 间充质干细胞的肿瘤归巢特性及其肿瘤靶向治疗应用研究进展[J]. 浙江大学学报（医学版）, 2020, 49(1): 20-34.
[10] 黄耀凭,杨凤,周天华,谢珊珊. Hippo信号通路及其在消化系统肿瘤中的作用研究进展[J]. 浙江大学学报（医学版）, 2020, 49(1): 35-43.
[11] 钟文,楼燕,邱宸阳,李栋林,张鸿坤. 髂静脉支架植入术后药物治疗策略研究进展[J]. 浙江大学学报（医学版）, 2020, 49(1): 131-136.
[12] 徐亦鸣,应可净. 中性粒细胞胞外诱捕网与肿瘤相关研究进展[J]. 浙江大学学报（医学版）, 2020, 49(1): 107-112.
[13] 刘晓晓,郭莉琼,梁成. 抗N-甲基-D-天冬氨酸受体脑炎患者脑电图特点的研究进展[J]. 浙江大学学报（医学版）, 2020, 49(1): 118-123.
[14] 方娟,潘志成,郭晓纲. INK4基因座中反义非编码RNA调控细胞增殖与凋亡影响动脉粥样硬化的研究进展[J]. 浙江大学学报（医学版）, 2020, 49(1): 113-117.
[15] 王诗莹,顾新华. 种植前辅助正畸治疗的临床应用研究进展[J]. 浙江大学学报（医学版）, 2020, 49(1): 124-130.